Skip to content

To Examine the effect of Pippali Lavan Ela Pratisaran in people with complains of Vattaj Mukhapaka (Stomatitis).

Randomized Controlled Clinical Trail to evaluate the efficacy of Pippali Lavan Ela Pratisaran in the managment of Vattaj Mukhapaka with special reference to Stomatitis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104295
Enrollment
60
Registered
2026-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K121- Other forms of stomatitis

Interventions

None listed

Sponsors

Dr Het Kiran Mamaniya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Paitent having sign and symptoms of Vattaj Mukhapaka ie., Pidayukta vran (painful ulcer),Arun vran (white ulcer),Ruksha vran, Tamra ostha(redness of lips),Jivha guruta (heaviness of tongue),Kantakyukta jivha (prickling sensations of tongue) 2)Selection will be irrespective of sex, religion and socio economical class. 3) Paitents of either sex within age group of 18-60yrs. 4) Paitents who will give voluntary consent for the study.

Exclusion criteria

Exclusion criteria: 1) Paitents diagnosed oral malignancy. 2) Paitents age below 18yrs and above 60 yrs. 3)Paitents not willing for clinical trail and written consent. 4) Paitent with oral candidiasis. 5) Paitent with severe anemia.

Design outcomes

Primary

MeasureTime frame
Efficacy of Pippali Lavan Ela Pratisaran in Vattaj MukhapakaTimepoint: 7 days

Secondary

MeasureTime frame
To study classical literature of Mukhapaka VyadhiTimepoint: 7 days;To study Pratisaran vidhi in detailTimepoint: 7 days

Countries

India

Contacts

Public ContactDr Het Kiran Mamaniya

LKR Ayurvedic College and Research Centre

drsutaryuvrajmsophth@gmail.com9850544418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026